Direct Oral Anticoagulants vs Low–Molecular-Weight Heparin for Preventing Recurrent Venous Thromboembolism in Patients With Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial
JAMA 2023 Jun 02;[EPub Ahead of Print], D Schrag, H Uno, R Rosovsky, C Rutherford, K Sanfilippo, JL Villano, M Drescher, N Jayaram, C Holmes, L Feldman, O Zattra, H Farrar-Muir, C Cronin, E Basch, A Weiss, JM ConnorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.